The Taiwan Society of Cardiology (TSOC) was founded in 1960, and counts more than 1,700 cardiologists among its active membership. Acta Cardiologica Sinica, the official journal of TSOC,  has been published quarterly since 1985, and bimonthly since 2013.

Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.

Acta Cardiologica Sinica was listed in SCIe in 2007, and had an impact factor (IF) of 0.253 by 2009. The IF is 0.845 in 2014. We continuously seek to maintain and enhance this fine tradition of excellence, with continuing efforts to increase the impact factor of the journal, a persistent mission of the publication committee and the editorial team. The broader visibility of our journal is important as a mechanism to increase its impact factor, where easier access to our publication would produce opportunities for a regional and even worldwide audience to read and thereafter cite the articles in our journal related to their own research fields.